Archive for April, 2007

For those in the NJ area, we have couple of excellent learning opportunities coming up:

Thursday, May 10 – Karl Kapp on training the younger generation (the Gamers)

Thursday, June 14 – Kee Meng Yeo (recently of J&J) on the use of Learning Technology

Both of these events are to be held in Princeton, starting at 6:00 pm.

Full descriptions, and sign up here.

Read Full Post »

If you’re investigating the use of a  learning management system, or seeking to explore how to put eLearning (on-line courseware, webcasting, etc.) to use – I can help. Lots of practical and technical experience in those areas.

Read Full Post »

Fabulous 3-D Animation

What goes on during normal birth. If you’re looking for a very cool, medically accurate, yet modest way to explain the birth process to your kids, here’s the animation for you…

Read Full Post »

Sanofi-Aventis’ Ambien about to get generic competition. But, some good news on the Lovenox front.

Pfizer gets a major slap for old Pharmacia marketing practices with Genotropin.

Glaxo gets an approval for Veramyst (allergy treatment).

WSJ Health blog speculates “who’s next?“, after MedImmune sale to AstraZeneca.

Novartis reports strong Q1 financial results.

Merck’s Arcoxia goes down for the FDA count.

Read Full Post »

Using a very cool free web service (Pageflakes), I pulled together a portal that consolidates a bunch of pharma blogs into one easy-to-navigate portal. You can visit PharmaCentral to get a daily update on pharmaceutical news, as well as check out postings on other topics such as Training and Marketing. Enjoy!

Read Full Post »

Starting with a promising blood clot medicine, now in the research phase.

There’s been plenty of talk about Bristol being on the block of late, and of course, there’s a certain history with Pfizer co-promote partners.


Read Full Post »

You mean…sales reps are supposed to relate to doctors? And their visits are for the purpose of influencing?

Why hadn’t anyone studied that before?

Article here, study abstract here (at least there are a few interesting nuggets of info – esp. about off-label detailing – in the abstract).

More scrutiny on the “coziness” of the doctor-sales rep relationship here.

And a very interesting (longer) story about one rep who called himself “almost a criminal” here.

Hat tip: Bill Senger

Read Full Post »

Older Posts »